Catalyst Wire Dossier Catalyst Wire Dossier

peficitinib

peficitinib · Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for peficitinib, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

See pricing